MONTVALE, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) announced today that it will report its third quarter
financial results on Thursday, November 8, 2007, before the U.S. financial
markets open. Management will provide a Company update and discuss the third
quarter results during a conference call on Thursday, November 8, 2007, at
9:00 a.m. ET.
Investors and other interested parties may access the call as follows:
Date: Thursday, November 8, 2007
Time: 9:00 a.m. ET
Telephone (U.S.): 866.314.9013
Telephone (international): 617.213.8053
Participant Passcode: 64962595
Webcast: http://www.memorypharma.com under the
"Investors" section
An audio replay of the conference call will be available from
11:00 a.m. ET on Thursday, November 8, 2007, until Thursday,
November 15, 2007. To access the replay, please dial 888.286.8010 (U.S.) or
617.801.6888 (international) and enter pass code number 43832722. An audio
replay of the conference call will also be available under the "Investors"
section of the Company's website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 11/02/2007
/CONTACT: Jzaneen Lalani, General Counsel of Memory Pharmaceuticals
Corp., +1-201-802-7249; or Laura Perry of Stern Investor Relations, Inc.,
+1-212-362-1200, for Memory Pharmaceuticals Corp./
/Web site: http://www.memorypharma.com /
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey
IN: HEA BIO MTC
SU: CCA
CA-WR
-- NYF065 --
2288 11/02/2007 12:05 EDT http://www.prnewswire.com
